ANNEX 
CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND 
EFFECTIVE USE OF THE MEDICINAL PRODUCT TO BE IMPLEMENTED 
BY THE MEMBER STATES 
1 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE 
OF MEDICINAL PRODUCT TO BE IMPLEMENTED BY THE MEMBER STATES 
The Member States should ensure that all conditions or restrictions with regard to the safe and 
effective use of the medicinal product described below are implemented: 
The MAH shall agree the details of an educational programme with the National Competent 
Authorities and must implement such programme nationally to ensure that, prior to prescribing, all 
physicians are provided with a healthcare professional information pack containing the following: 
•  Educational material 
•  Summary of Product Characteristics (SPC) and Package Leaflet and Labelling 
Key elements to be included in the educational material 
• 
• 
• 
• 
Posology 
Instructions for administration  
Information on gel depot formation and possible injections site reactions 
Information on the identified and potential risks. 
2 
 
 
 
 
  
